Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Seu

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
The American Journal of Gastroenterology|November 20, 1998
Resolution of recurrent hepatitis B in two liver transplant recipients treated with famciclovirS H Han, M Kinkhabwala, P Martin, et al.
Transplantation|June 3, 2000
Fas ligand gene transfer prolongs rat renal allograft survival and down-regulates anti-apoptotic Bag-1 in parallel with enhanced Th2-type cytokine expressionB Ke, A J Coito, H Kato, et al.
The Journal of Surgical Research|April 1, 1990
Anti-tumor necrosis factor antibody enhances allograft survival in ratsD K Imagawa, J M Millis, K M Olthoff, et al.
Transplantation Proceedings|February 1, 1991
Prolongation of hepatic allograft survival in rat recipients treated with anti-lymphotoxin antibodyK Teramoto, A Baquerizo, D K Imagawa, et al.
Transplantation|January 1, 1991
The role of tumor necrosis factor in allograft rejection. III. Evidence that anti-TNF antibody therapy prolongs allograft survival in rats with acute rejectionD K Imagawa, J M Millis, P Seu, et al.
Clinical Transplants|January 1, 1991
Liver transplantation at UCLA: report of clinical activitiesD K Imagawa, S M Strange, A Shaked, et al.
Human Gene Therapy|February 4, 1998
In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2L A Bui, L H Butterfield, J Y Kim, et al.
Transplantation|September 27, 1995
Lack of correlation between the magnitude of preservation injury and the incidence of acute rejection, need for OKT3, and conversion to FK506 in cyclosporine-treated primary liver allograft recipientsC R Shackleton, P Martin, J Melinek, et al.
Annals of Surgery|January 1, 1991
Liver transplantation in childrenR W Busuttil, P Seu, J M Millis, et al.
Transplantation|August 1, 1990
The role of tumor necrosis factor in allograft rejection. II. Evidence that antibody therapy against tumor necrosis factor-alpha and lymphotoxin enhances cardiac allograft survival in ratsD K Imagawa, J M Millis, K M Olthoff, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
The American Journal of Gastroenterology|November 20, 1998
Resolution of recurrent hepatitis B in two liver transplant recipients treated with famciclovirS H Han, M Kinkhabwala, P Martin, et al.
Transplantation|June 3, 2000
Fas ligand gene transfer prolongs rat renal allograft survival and down-regulates anti-apoptotic Bag-1 in parallel with enhanced Th2-type cytokine expressionB Ke, A J Coito, H Kato, et al.
The Journal of Surgical Research|April 1, 1990
Anti-tumor necrosis factor antibody enhances allograft survival in ratsD K Imagawa, J M Millis, K M Olthoff, et al.
Transplantation Proceedings|February 1, 1991
Prolongation of hepatic allograft survival in rat recipients treated with anti-lymphotoxin antibodyK Teramoto, A Baquerizo, D K Imagawa, et al.
Transplantation|January 1, 1991
The role of tumor necrosis factor in allograft rejection. III. Evidence that anti-TNF antibody therapy prolongs allograft survival in rats with acute rejectionD K Imagawa, J M Millis, P Seu, et al.
Clinical Transplants|January 1, 1991
Liver transplantation at UCLA: report of clinical activitiesD K Imagawa, S M Strange, A Shaked, et al.
Human Gene Therapy|February 4, 1998
In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2L A Bui, L H Butterfield, J Y Kim, et al.
Transplantation|September 27, 1995
Lack of correlation between the magnitude of preservation injury and the incidence of acute rejection, need for OKT3, and conversion to FK506 in cyclosporine-treated primary liver allograft recipientsC R Shackleton, P Martin, J Melinek, et al.
Annals of Surgery|January 1, 1991
Liver transplantation in childrenR W Busuttil, P Seu, J M Millis, et al.
Transplantation|August 1, 1990
The role of tumor necrosis factor in allograft rejection. II. Evidence that antibody therapy against tumor necrosis factor-alpha and lymphotoxin enhances cardiac allograft survival in ratsD K Imagawa, J M Millis, K M Olthoff, et al.
Pageof 5